eToke + TPsy for Cannabis Use

Rhode Island Hospital, Providence, RI
Cannabis Use+1 More ConditionseToke + TPsy - Behavioral
Eligibility
18 - 28
All Sexes
What conditions do you have?
Select

Study Summary

This trial is investigating whether adding text messages to a computerized intervention called e-Toke will help young adults in psychiatric treatment reduce their cannabis use.

Eligible Conditions
  • Cannabis Use
  • Mental Illness

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3
N/A

Study Objectives

4 Primary · 2 Secondary · Reporting Duration: Assessed at weeks 2, 4, 5, 6, 7, 8, 9, 10, and 11

Week 12
Change in Self-reported Motivation to Reduce Cannabis Use (DBI)
Change in Self-reported Motivation to Reduce Cannabis Use (Readiness Ruler)
Change in Self-reported Motivation to Reduce Cannabis Use (SOCRATES)
Change in Self-reported Psychiatric Symptoms
Change in Self-reported Self-efficacy to Reduce Cannabis Use (SCQ-8)
Week 2
Change in Self-reported Frequency of Cannabis Use

Trial Safety

Phase-Based Safety

1 of 3

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

1 Treatment Group

eToke + TPsy
1 of 1

Experimental Treatment

50 Total Participants · 1 Treatment Group

Primary Treatment: eToke + TPsy · No Placebo Group · N/A

eToke + TPsy
Behavioral
Experimental Group · 1 Intervention: eToke + TPsy · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: assessed at weeks 2, 4, 5, 6, 7, 8, 9, 10, and 11

Who is running the clinical trial?

Rhode Island HospitalLead Sponsor
242 Previous Clinical Trials
66,578 Total Patients Enrolled
Laura Whiteley, MDPrincipal InvestigatorRhode Island Hospital
3 Previous Clinical Trials
248 Total Patients Enrolled
Larry Brown, MDPrincipal InvestigatorRhode Island Hospital
3 Previous Clinical Trials
298 Total Patients Enrolled

Eligibility Criteria

Age 18 - 28 · All Participants · 2 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are at a high risk of developing psychosis based on mental health guidelines.
You use cannabis at least twice a week.
References

Frequently Asked Questions

Is this investigation actively enrolling participants?

"Data on clinicaltrials.gov suggest that this research study is presently recruiting participants. The trial was initially announced November 1st 2019, and its details were most recently edited October 19th 2022." - Anonymous Online Contributor

Unverified Answer

What is the current allotment of participants for this clinical assessment?

"Affirmative, the clinicaltrials.gov website displays that this medical trial is proactively seeking out participants since its inception on November 1st 2019 and most recent update on October 19th 2022. The study needs 50 individuals to be recruited from one location." - Anonymous Online Contributor

Unverified Answer

Is the upper age limitation of this trial above seventy years old?

"The eligibility requirements for this clinical trial specify that the minimum age of participants must be 18 and not higher than 28." - Anonymous Online Contributor

Unverified Answer

Could I potentially qualify to participate in this clinical experiment?

"For this clinical trial, 50 young adults aged 18 to 28 with hashish abuse must be found. Prerequisites for applicants include: English fluency, weekly cannabis consumption of two or more instances, a functional cellular phone that is able to receive textual messages, and psychiatric care from the Young Adult Behavioral Health Program at Rhode Island Hospital in addition to meeting high risk criteria for psychosis as outlined by mental health standards." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.